Zelapar (Valeant) 2017-2018 U.S. Promotional Audit Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 24, 2018--The “Zelapar 2017 U.S. Promotional Audit Report” report has been added to ResearchAndMarkets.com’s offering.
The 5 Key Questions AddressedHow many physicians were reached by Zelapar through reportable promotional activity in 2017 and how does this compare to its peer set in the Parkinson’s Disease market? What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity? How does Valeant’s depth of coverage vary within key specialties (e.g., Neurology, Family Medicine, and Internal Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians? How often are physicians receiving paid meals for Zelapar throughout the year (e.g., monthly, quarterly, annually)? Who were the most frequent meal recipients and top paid speakers for Zelapar in 2017?
Data Sources & MethodologyThe author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. More than four years of longitudinal data is available - covering payments to more than 975,000 U.S. healthcare professionals. Over 400 paid interactions across 400 physicians made on behalf of Zelapar were carefully examined to support the analysis.
For more information about this report visit https://www.researchandmarkets.com/research/g4qtsb/zelapar_valeant?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180924005452/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Central Nervous System Drugs
KEYWORD: UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/24/2018 07:23 AM/DISC: 09/24/2018 07:23 AM